We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+0.25%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$119B
AUM Growth
+$5.64B
(+5%)
Cap. Flow
+$6.41B
Cap. Flow
% of AUM
5.41%
Top 10 Holdings %
Top 10 Hldgs %
16.36%
Holding
4,406
New
331
Increased
2,055
Reduced
1,449
Closed
309
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.02B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$944M |
| 3 |
AT&T
T
|
+$753M |
| 4 |
Vanguard Extended Market ETF
VXF
|
+$553M |
| 5 |
Linde
LIN
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$331M |
| 2 |
FDC
First Data Corporation
FDC
|
+$331M |
| 3 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$312M |
| 4 |
Blackstone
BX
|
+$277M |
| 5 |
FirstEnergy
FE
|
+$261M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.59% |
| 2 | Technology | 10.75% |
| 3 | Financials | 9.31% |
| 4 | Consumer Discretionary | 6.45% |
| 5 | Communication Services | 5.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WIRE
2926
DELISTED
Encore Wire Corp
WIRE
| $1M | ﹤0.01% |
17,831
+1,559
| +10% | +$86.4K |
|
2927
GrafTech
EAF
$195M
| $1M | ﹤0.01% |
7,818
-285
| -4% | -$33.9K |
|
2928
Telkom Indonesia
TLK
$15B
| $1M | ﹤0.01% |
33,245
-267,361
| -89% | -$8.07M |
|
2929
Kulicke & Soffa
KLIC
$4.72B
| $1M | ﹤0.01% |
42,596
+1,408
| +3% | +$30.9K |
|
2930
Bilibili
BILI
$8.05B
| $998K | ﹤0.01% |
70,716
-40,216
| -36% | -$604K |
|
2931
TransAlta
TAC
$3.9B
| $997K | ﹤0.01% |
153,281
-124,089
| -45% | -$787K |
|
2932
iShares MSCI India Small-Cap ETF
SMIN
$764M
| $994K | ﹤0.01% |
28,280
+7,400
| +35% | +$258K |
|
2933
Invesco KBW Premium Yield Equity REIT ETF
KBWY
$314M
| $991K | ﹤0.01% |
31,747
+9,581
| +43% | +$286K |
|
2934
Scholastic
SCHL
$794M
| $990K | ﹤0.01% |
26,226
+3,758
| +17% | +$132K |
|
2935
News Corp Class B
NWS
$17.2B
| $986K | ﹤0.01% |
69,052
-18,635
| -21% | -$261K |
|
2936
Medifast
MED
$108M
| $982K | ﹤0.01% |
9,473
-6,598
| -41% | -$709K |
|
2937
Oxford Industries
OXM
$568M
| $982K | ﹤0.01% |
13,686
+2,633
| +24% | +$185K |
|
2938
AMERISAFE
AMSF
$564M
| $981K | ﹤0.01% |
14,828
+1,051
| +8% | +$69.7K |
|
|
FOE
2939
DELISTED
Ferro Corporation
FOE
| $976K | ﹤0.01% |
82,383
+11,697
| +17% | +$148K |
|
2940
Stewart Information Services
STC
$2.1B
| $975K | ﹤0.01% |
25,135
+4,138
| +20% | +$154K |
|
2941
Usana Health Sciences
USNA
$422M
| $974K | ﹤0.01% |
14,239
-31,957
| -69% | -$2.15M |
|
2942
Varex Imaging
VREX
$502M
| $974K | ﹤0.01% |
34,123
-2,643
| -7% | -$76.5K |
|
|
RAVN
2943
DELISTED
Raven Industries Inc
RAVN
| $974K | ﹤0.01% |
29,076
+3,817
| +15% | +$128K |
|
2944
Stoneridge
SRI
$210M
| $971K | ﹤0.01% |
31,344
+14,849
| +90% | +$466K |
|
2945
Teekay
TK
$1.03B
| $971K | ﹤0.01% |
242,561
+1,612
| +0.7% | +$6.45K |
|
|
NTUS
2946
DELISTED
Natus Medical Inc
NTUS
| $971K | ﹤0.01% |
30,480
+1,511
| +5% | +$44K |
|
2947
Enerpac Tool Group
EPAC
$1.85B
| $969K | ﹤0.01% |
44,136
+4,189
| +10% | +$95.9K |
|
|
NTZ
2948
Natuzzi
NTZ
$14.2M
| $968K | ﹤0.01% |
551,980
| – | – |
|
|
NS
2949
DELISTED
NuStar Energy L.P.
NS
| $968K | ﹤0.01% |
34,172
-79,055
| -70% | -$2.2M |
|
|
HA
2950
DELISTED
Hawaiian Holdings, Inc.
HA
| $967K | ﹤0.01% |
36,797
-11,447
| -24% | -$301K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q3 2019 Portfolio in Review
As of Q3 2019, Credit Suisse held 4,406 positions worth $119B, up 5% from $113B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Credit Suisse deployed $6.41B of net new capital in Q3 2019, opening 331 new positions and adding to 2,055 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Genesee & Wyoming Inc., an estimated $312M trimmed.
- Credit Suisse's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
- Credit Suisse added most to Allergan plc in Q3 2019, an estimated $1.02B increase.
- Credit Suisse's biggest Q3 2019 reduction was Genesee & Wyoming Inc., cutting an estimated $312M.
- Credit Suisse fully exited Anadarko Petroleum in Q3 2019, selling an estimated $331M.
- Credit Suisse's ten largest holdings make up 16% of its $119B portfolio in Q3 2019.
- Credit Suisse opened 331 new positions and closed 309 in Q3 2019.
- Credit Suisse's portfolio value rose 5% quarter-over-quarter to $119B.
Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.